Van Gennip AH - Search Results

1

Profound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients.

Van Kuilenburg AB, van Lenthe H, Blom MJ, Mul EP, Van Gennip AH. Van Kuilenburg AB, et al. Among authors: van gennip ah, van lenthe h. Br J Cancer. 1999 Feb;79(3-4):620-6. doi: 10.1038/sj.bjc.6690097. Br J Cancer. 1999. PMID: 10027339 Free PMC article.

2

New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?

Van Kuilenburg AB, Stroomer AE, Van Lenthe H, Abeling NG, Van Gennip AH. Van Kuilenburg AB, et al. Among authors: van gennip ah, van lenthe h. Biochem J. 2004 Apr 1;379(Pt 1):119-24. doi: 10.1042/BJ20031463. Biochem J. 2004. PMID: 14705962 Free PMC article.

3

Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation.

Van Kuilenburg AB, Meinsma R, Zoetekouw L, Van Gennip AH. Van Kuilenburg AB, et al. Among authors: van gennip ah. Int J Cancer. 2002 Sep 20;101(3):253-8. doi: 10.1002/ijc.10599. Int J Cancer. 2002. PMID: 12209976 Free article.

4

High prevalence of the IVS14 + 1G>A mutation in the dihydropyrimidine dehydrogenase gene of patients with severe 5-fluorouracil-associated toxicity.

Van Kuilenburg AB, Meinsma R, Zoetekouw L, Van Gennip AH. Van Kuilenburg AB, et al. Among authors: van gennip ah. Pharmacogenetics. 2002 Oct;12(7):555-8. doi: 10.1097/00008571-200210000-00007. Pharmacogenetics. 2002. PMID: 12360106

5

Pharmacogenetic and clinical aspects of dihydropyrimidine dehydrogenase deficiency.

van Kuilenburg AB, De Abreu RA, van Gennip AH. van Kuilenburg AB, et al. Among authors: van gennip ah. Ann Clin Biochem. 2003 Jan;40(Pt 1):41-5. doi: 10.1258/000456303321016150. Ann Clin Biochem. 2003. PMID: 12542909 Review.

6

Identification and tissue-specific expression of a NADH-dependent activity of dihydropyrimidine dehydrogenase in man.

Van Kuilenburg AB, Van Lenthe H, Van Gennip AH. Van Kuilenburg AB, et al. Among authors: van gennip ah, van lenthe h. Anticancer Res. 1996 Jan-Feb;16(1):389-94. Anticancer Res. 1996. PMID: 8615641

7

The activity of dihydropyrimidine dehydrogenase in human blood cells.

Van Kuilenburg AB, Blom MJ, Van Lenthe H, Mul E, Van Gennip AH. Van Kuilenburg AB, et al. Among authors: van gennip ah, van lenthe h. J Inherit Metab Dis. 1997 Jul;20(3):331-4. doi: 10.1023/a:1005305323052. J Inherit Metab Dis. 1997. PMID: 9266348 No abstract available.

8

Subcellular localization of dihydropyrimidine dehydrogenase.

Van Kuilenburg AB, Van Lenthe H, Wanders RJ, Van Gennip AH. Van Kuilenburg AB, et al. Among authors: van gennip ah, van lenthe h. Biol Chem. 1997 Sep;378(9):1047-53. doi: 10.1515/bchm.1997.378.9.1047. Biol Chem. 1997. PMID: 9348115

9

Dihydropyrimidine dehydrogenase (DPD) deficiency: identification and expression of missense mutations C29R, R886H and R235W.

Vreken P, Van Kuilenburg AB, Meinsma R, van Gennip AH. Vreken P, et al. Among authors: van gennip ah, van kuilenburg ab. Hum Genet. 1997 Dec;101(3):333-8. doi: 10.1007/s004390050637. Hum Genet. 1997. PMID: 9439663

10

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity.

Van Kuilenburg AB, Vreken P, Beex LV, Meinsma R, Van Lenthe H, De Abreu RA, van Gennip AH. Van Kuilenburg AB, et al. Among authors: van gennip ah, van lenthe h. Eur J Cancer. 1997 Nov;33(13):2258-64. doi: 10.1016/s0959-8049(97)00261-x. Eur J Cancer. 1997. PMID: 9470816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page